ARCHIVES

RFP: Intellectual Property.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013

Interview: “People don’t understand Clinical Trials.

September 5, 1997

Cancer Control Program Guidelines Developed For Payment Of Patient Costs

December 21, 1973

Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.

September 29, 2006

Electric Blankets May Be Risk Factor In Childhood Cancer

May 18, 1990

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

March 26, 1976